News

Pharma industry news from across the globe

New COVID-19 cases rose for 7th consecutive week, with India in the lead: WHO report – Express Healthcare

Read Article Number of countries reporting variants of concern continue to increase too As per WHO’s weekly epidemiological update on COVID-19 dated April 13, based on data received by from national authorities as of 10am CET April 11, India reported the highest numbers of new cases (873 296 new cases; with a 70 per cent …

New COVID-19 cases rose for 7th consecutive week, with India in the lead: WHO report – Express Healthcare Read More »

Misuse of natural resources leads to 19 mn premature deaths annually: UN report – Express Healthcare

Read Article The major direct damages caused to health is estimated to be $2-4 billion annually by 2030: Atul Bagai, Head India Country Office, UN Environment India The World Health Day is symbolic to inculcate health awareness across the globe. Unlike every year, the focus this year 2021 is somewhat different i.e., ‘to ensure equitable …

Misuse of natural resources leads to 19 mn premature deaths annually: UN report – Express Healthcare Read More »

EU Commission to end AstraZeneca and J&J vaccine contracts at expiry – paper – ET HealthWorld

Milan: The EU Commission has decided not to renew Covid-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday, citing a source from the Italian health ministry. “The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the …

EU Commission to end AstraZeneca and J&J vaccine contracts at expiry – paper – ET HealthWorld Read More »

AstraZeneca’s drug Tagrisso gets China nod for early lung cancer treatment – ET HealthWorld

– AstraZeneca Plc said on Wednesday that China’s health regulator expanded the use of Tagrisso, the British drugmaker‘s lung cancer treatment, in patients with a type of lung cancer when diagnosed at an early stage. China’s National Medical Products Administration (NMPA) approved Tagrisso as an adjuvant therapy for patients with early-stage lung cancer who have …

AstraZeneca’s drug Tagrisso gets China nod for early lung cancer treatment – ET HealthWorld Read More »

AYUSH Ministry’s manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 crore – ET HealthWorld

With its products attracting more buyers, Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Ministry of AYUSH, has recorded its highest-ever turnover of Rs 164 crore in 2020-21. The company has recorded an all-time high profit of approximately Rs 12 crore, the AYUSH Ministry said. Its previous highest turnover was …

AYUSH Ministry’s manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 crore – ET HealthWorld Read More »

Pfizer, Myovant begin dosing in relugolix contraceptive study

Pfizer and Myovant have announced that dosing has begun in a Phase III study evaluating the contraceptive efficacy of their relugolix combination tablet. The relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) will be evaluated in healthy women aged 18-35 years who are at risk for …

Pfizer, Myovant begin dosing in relugolix contraceptive study Read More »

Gilead’s Trodelvy scores accelerated approval in advanced bladder cancer

Gilead’s antibody drug conjugate (ADC) Trodelvy has received an accelerated approval from the US Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic urothelial cancer (UC), the most common form of bladder cancer. The approval covers the use of Trodelvy (sacituzumab govitecan-hziy) in patients with advanced UC who …

Gilead’s Trodelvy scores accelerated approval in advanced bladder cancer Read More »

UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded

A UK trial evaluating the safety of mixing different COVID-19 vaccines is set to be expanded to include Moderna and Novavax’s respective jabs. The Com-Cov study, announced earlier this year, is the first trial in the world to evaluate the effects of using different COVID-19 vaccines for the first and second dose …

UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded Read More »

Receive industry updates via newsletters. Subscribe now.

Be Resourceful, Be Updated.

Welcome Insider. Check you inbox / spam box for welcome message. Thankyou ! (Don't forget to mark the Email as safe.)

Please try again.